The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Webinar, FAQ Report & Decision Aid | COVID-19 & Neuromuscular Disorders: Ask The Experts

Muscular Dystrophy Canada (MDC) and the Neuromuscular Disease Network for Canada (NMD4C) have received numerous questions about COVID-19 vaccines and how they may uniquely affect people with neuromuscular disorders (NMD).

To address these questions and concerns, MDC & NMD4C assembled a diverse group of neuromuscular, virology, and policy experts to host a webinar with the purpose of answering these topical questions.

From this expert-led webinar, the MDC & NMD4C have developed a frequently asked questions report and decision aid tool as resources to summarize the experts’ answers, and to provide guidance for informed patient decision making.

You can access the Frequently Asked Questions Report, Decision Aid, and webinar recording below!

 

Report: Frequently Asked Questions – COVID-19 & Neuromuscular Disorders

 

Decision Aid: I have a NMD, should I get a vaccine for COVID-19

We are excited to have the following experts address questions about NMDs, COVID-19 and vaccines:

  • Dr. Hans Katzberg, adult neuromuscular specialist and NMD researcher
  • Dr. Hanns Lochmuller, pediatric neuromuscular specialist and NMD researcher
  • Dr. Reshma Amin, respirologist and NMD researcher
  • Dr. Megan Bettle, Director of the COVID-19 Regulatory Response Team at Health Canada / Government of Canada
  • Dr. Allison McGeer, Infectious Disease Specialist and COVID-19 researcher
  • Dr. Anne Pham-Huy, Infectious Disease Specialist and Chair of Immunize Canada
Ask the Experts COVID 19

Read next...

logos-treat-nmd-logo

NMD4C steering committee member Dr. Jim Dowling appointed Chair of the executive committee of TREAT-NMD

The NMD4C would like to congratulate our Steering Committee member Dr. Jim Dowling on his appointment as Chair of the executive committee of TREAT-NMD!

ENMC logo topkwaliteit

Launch of ENMC Mid-Career Mentoring Programme

Building from the success of the ENMC Early-Career Programme, the ENMC is proud to launch a new and ambitious Mid-Career Mentoring Programme.

image001

Rare Disease Day 2021 Recap

Observed annually on the last day of February, Rare Disease Day seeks to raise awareness among the general public, as well as policymakers, public authorities, industry representatives, scientists, and health professionals.   Due to the COVID-19 pandemic, activities this year were mainly virtual. But that did not stop patients, caregivers, researchers, clinicians, advocates and patient…

International DM day announced

International Myotonic Dystrophy Awareness Day Declared for September 15, 2021

The NMD4C are proud to be a part of a global alliance of myotonic dystrophy-focused organisations who in honour of Rare Disease Day 2021 have united to announce the declaration of International Myotonic Dystrophy Awareness Day to be observed each September 15th.

vaccine_stock

MDC Press Release | Muscular Dystrophy Canada calls on provincial governments to prioritize persons affected by neuromuscular disorders for COVID-19 vaccine

As the voice of the NMD community in Canada, Muscular Dystrophy Canada (MDC) is calling on governments to prioritize people living with hereditary and acquired neuromuscular disorders in their vaccination roll-out.

JND_CNDR_newsitem Logo

News Release: Neuromuscular Disease Registry Helps Patients Access Research, Clinical Trials, New Genetic Tests, and Therapies

With data on more than 4,000 patients, the Canadian Neuromuscular Disease Registry celebrates a decade of facilitating research across Canada, reports the Journal of Neuromuscular Diseases   The Canadian Neuromuscular Disease Registry (CNDR) was launched in 2010 to increase efficient patient access to cutting-edge research and clinical trials, to increase understanding of the natural history…